Pazopanib: Difference between revisions
From IDWiki
(Created page with "* Tyrosine kinase inhibitor * Indicated for renal cell carcinoma and soft tissue sarcoma Category:Tyrosine kinase inhibitors") |
No edit summary |
||
| Line 1: | Line 1: | ||
* Tyrosine kinase inhibitor |
* Tyrosine kinase inhibitor |
||
* Inhibits multiple targets, including vascular endothelial growth factor receptor (VEGFR), platelet-derived growth factor receptor (PDGFR), c-KIT, and FGFR |
|||
* Indicated for [[renal cell carcinoma]] and [[soft tissue sarcoma]] |
* Indicated for [[renal cell carcinoma]] and [[soft tissue sarcoma]] |
||
Latest revision as of 14:05, 9 August 2023
- Tyrosine kinase inhibitor
- Inhibits multiple targets, including vascular endothelial growth factor receptor (VEGFR), platelet-derived growth factor receptor (PDGFR), c-KIT, and FGFR
- Indicated for renal cell carcinoma and soft tissue sarcoma
